Search

Author/Creator Sayehli, Cyrus

1. ATIM-49 (LTBK-01). AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE®) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM). (22nd November 2019)

Authors:
Rosenthal, Mark A; Balana, Carmen; van Linde, Myra E; Sayehli, Cyrus; Fiedler, Walter M; Wermke, Martin; Massard, Christophe; Mellinghoff, Ingo K; Khasraw, Mustafa; Ang, Agnes; Rasmussen, Erik; Kast, Johannes; Stienen, Sabine; Cloughesy, Timothy F
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 6
Page Start:
vi283
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase I study of domatinostat (4SC‐202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies. (7th January 2019)

Authors:
von Tresckow, Bastian; Sayehli, Cyrus; Aulitzky, Walter E.; Goebeler, Maria‐Elisabeth; Schwab, Matthias; Braz, Eunice; Krauss, Babett; Krauss, Rolf; Hermann, Frank; Bartz, René; Engert, Andreas
Journal:
European journal of haematology
Issue:
Volume 102:Number 2(2019)
Page Start:
163
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search